Physician profile
Mark E Woolley
NPI 1629213780
$5,649.58
in general payments reported to CMS, 2019-2025
29 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.53 · 2020: $52.09 · 2021: $4,029 · 2022: $680 · 2023: $77.66 · 2024: $393 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $2,476.19 | 2021-2024 | |
| Arthrex, INC. | $1,496.00 | 2021 | |
| Treace Medical Concepts, INC. | $610.18 | 2022-2025 | |
| Stryker Corporation | $213.72 | 2019-2025 | Variax, Flexband, N/A |
| Orthofix Medical, INC. | $105.66 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $80.76 | 2020-2024 | Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Dynasplint Systems INC. | $78.70 | 2021-2025 | Dynasplint |
| In2bones USA, LLC | $72.92 | 2021-2022 | |
| Bioventus LLC | $66.84 | 2020-2022 | |
| Integra Lifesciences Corporation | $61.17 | 2020-2021 | |
| Anika Therapeutics, INC. | $42.45 | 2024-2025 | Tactoset, Integrity Implant |
| Solventum Corporation | $39.68 | 2025 | Prevena, Promogran Prisma, Activ.A.C. |
| Checkpoint Surgical, INC | $38.56 | 2024 | Checkpoint Stimulators |
| Paragon 28, INC. | $26.16 | 2024 | Precision Guide Lapidus |
| Mimedx Group, INC. | $24.68 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $22.00 | 2024 | |
| Abbvie INC. | $17.90 | 2024 | |
| Medtronic, INC. | $17.54 | 2025 | Inceptiv |
| Globus Medical, INC. | $16.85 | 2023 | Ankle Fracture System |
| Heron Therapeutics, INC. | $16.52 | 2021 | |
| Allergan, INC. | $15.94 | 2019 | |
| Averitas Pharma INC. | $15.62 | 2025 | Qutenza |
| Grt US Holding, INC. | $15.33 | 2022 | |
| Innovation Technologies INC | $15.08 | 2024 | Irrisept |
| Zyla Life Sciences, INC. | $13.35 | 2020 | |
| Polynovo North America LLC | $13.25 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $12.68 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.35 | 2022 | |
| Organogenesis INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Woolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.